Drug Combination Details
| General Information of the Combination (ID: C47170) | |||||
|---|---|---|---|---|---|
| Name | Luteolin NP Info | + | Imatinib Drug Info | ||
| Structure |
|
+ |
|
||
| Disease |
Chronic myelogenous leukaemia
[ICD-11: 2A20]
|
Investigative | [1] | ||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Augmenting Drug Sensitivity | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [1] | |||||
| In-vitro Model | K-562 | CVCL_0004 | Chronic myelogenous leukemia | Homo sapiens | ||
| Experimental
Result(s) |
Combination treatment may provide better outcomes in terms of cytotoxicity and thus reduce the dosages of imatinib used. | |||||